These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 25093529)

  • 41. Complement in glomerulonephritis.
    Welch TR
    Nat Genet; 2002 Aug; 31(4):333-4. PubMed ID: 12091912
    [No Abstract]   [Full Text] [Related]  

  • 42. The anti-factor D antibody, MAb 166-32, inhibits the alternative pathway of the human complement system.
    Tanhehco EJ; Kilgore KS; Liff DA; Murphy KL; Fung MS; Sun WN; Sun C; Lucchesi BR
    Transplant Proc; 1999 Aug; 31(5):2168-71. PubMed ID: 10456004
    [No Abstract]   [Full Text] [Related]  

  • 43. Complement C3d/C4d Deposition on Platelets Correlates with 2'-O-Methoxyethyl Antisense Oligonucleotide-Induced Thrombocytopenia in Monkeys.
    Shen L; Wong A; Oneda S; Curtis BR; Schroeder J; Zanardi T; Engelhardt JA; Henry SP; Narayanan P
    Nucleic Acid Ther; 2023 Jun; 33(3):209-225. PubMed ID: 37093125
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Complement factor H family proteins in their non-canonical role as modulators of cellular functions.
    Józsi M; Schneider AE; Kárpáti É; Sándor N
    Semin Cell Dev Biol; 2019 Jan; 85():122-131. PubMed ID: 29305301
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human alternative pathway assay.
    Ramanathan VD
    Am J Clin Pathol; 1983 Sep; 80(3):412-3. PubMed ID: 6881107
    [No Abstract]   [Full Text] [Related]  

  • 46. Mechanistic understanding for the greater sensitivity of monkeys to antisense oligonucleotide-mediated complement activation compared with humans.
    Shen L; Frazer-Abel A; Reynolds PR; Giclas PC; Chappell A; Pangburn MK; Younis H; Henry SP
    J Pharmacol Exp Ther; 2014 Dec; 351(3):709-17. PubMed ID: 25301170
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activation of the alternative pathway of complement by a phosphorothioate oligonucleotide: potential mechanism of action.
    Henry SP; Giclas PC; Leeds J; Pangburn M; Auletta C; Levin AA; Kornbrust DJ
    J Pharmacol Exp Ther; 1997 May; 281(2):810-6. PubMed ID: 9152389
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antisense oligonucleotide therapies: the promise and the challenges from a toxicologic pathologist's perspective.
    Frazier KS
    Toxicol Pathol; 2015 Jan; 43(1):78-89. PubMed ID: 25385330
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficient Synthesis and Biological Evaluation of 5'-GalNAc Conjugated Antisense Oligonucleotides.
    Østergaard ME; Yu J; Kinberger GA; Wan WB; Migawa MT; Vasquez G; Schmidt K; Gaus HJ; Murray HM; Low A; Swayze EE; Prakash TP; Seth PP
    Bioconjug Chem; 2015 Aug; 26(8):1451-5. PubMed ID: 26011654
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nanocarriers in gene therapy: a review.
    Xu H; Li Z; Si J
    J Biomed Nanotechnol; 2014 Dec; 10(12):3483-507. PubMed ID: 26000367
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Complement involvement in kidney diseases: From physiopathology to therapeutical targeting.
    Salvadori M; Rosso G; Bertoni E
    World J Nephrol; 2015 May; 4(2):169-84. PubMed ID: 25949931
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vivo evaluation of candidate allele-specific mutant huntingtin gene silencing antisense oligonucleotides.
    Southwell AL; Skotte NH; Kordasiewicz HB; Østergaard ME; Watt AT; Carroll JB; Doty CN; Villanueva EB; Petoukhov E; Vaid K; Xie Y; Freier SM; Swayze EE; Seth PP; Bennett CF; Hayden MR
    Mol Ther; 2014 Dec; 22(12):2093-2106. PubMed ID: 25101598
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Results of a proof of concept, double-blind, randomized trial of a second generation antisense oligonucleotide targeting high-sensitivity C-reactive protein (hs-CRP) in rheumatoid arthritis.
    Warren MS; Hughes SG; Singleton W; Yamashita M; Genovese MC
    Arthritis Res Ther; 2015 Mar; 17(1):80. PubMed ID: 25885521
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of the alternative complement pathway by antisense oligonucleotides targeting complement factor B improves lupus nephritis in mice.
    Grossman TR; Hettrick LA; Johnson RB; Hung G; Peralta R; Watt A; Henry SP; Adamson P; Monia BP; McCaleb ML
    Immunobiology; 2016 Jun; 221(6):701-8. PubMed ID: 26307001
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A New Approach for the Treatment of Arthritis in Mice with a Novel Conjugate of an Anti-C5aR1 Antibody and C5 Small Interfering RNA.
    Mehta G; Scheinman RI; Holers VM; Banda NK
    J Immunol; 2015 Jun; 194(11):5446-54. PubMed ID: 25917104
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Complement factor H, vitronectin, and opticin are tyrosine-sulfated proteins of the retinal pigment epithelium.
    Kanan Y; Siefert JC; Kinter M; Al-Ubaidi MR
    PLoS One; 2014; 9(8):e105409. PubMed ID: 25136834
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New functional and structural insights from updated mutational databases for complement factor H, Factor I, membrane cofactor protein and C3.
    Rodriguez E; Rallapalli PM; Osborne AJ; Perkins SJ
    Biosci Rep; 2014 Oct; 34(5):. PubMed ID: 25188723
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Arterial thrombosis is accelerated in mice deficient in histidine-rich glycoprotein.
    Vu TT; Zhou J; Leslie BA; Stafford AR; Fredenburgh JC; Ni R; Qiao S; Vaezzadeh N; Jahnen-Dechent W; Monia BP; Gross PL; Weitz JI
    Blood; 2015 Apr; 125(17):2712-9. PubMed ID: 25691157
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of the toxicity of ISIS 2302, a phosphorothioate oligonucleotide, in a 4-week study in CD-1 mice.
    Henry SP; Taylor J; Midgley L; Levin AA; Kornbrust DJ
    Antisense Nucleic Acid Drug Dev; 1997 Oct; 7(5):473-81. PubMed ID: 9361906
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Complement factor C5a induces atherosclerotic plaque disruptions.
    Wezel A; de Vries MR; Lagraauw HM; Foks AC; Kuiper J; Quax PH; Bot I
    J Cell Mol Med; 2014 Oct; 18(10):2020-30. PubMed ID: 25124749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.